GlassScriptPhysician profile
Jennifer D Mcallaster
NPI 1851411466
$9,776.44
in general payments reported to CMS, 2019-2025
14 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,930 · 2020: $35.32 · 2021: $27.24 · 2022: $5,887 · 2023: $111 · 2024: $1,785.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $1,223 · Food and Beverage: $673.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $1,223.07 |
| Food and Beverage | $672.95 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $5,869.12 | 2020-2024 | |
| Medical Device Business Services, INC. | $1,704.10 | 2019-2024 | Linx Reflux Management System |
| Apollo Endosurgery US INC | $1,383.77 | 2019 | |
| Davol INC. | $341.38 | 2019-2024 | Optifix Open Absorbable Fixation System, Phasix Mesh |
| Medtronic, INC. | $127.21 | 2022-2024 | Endoflip |
| Ethicon US, LLC | $113.45 | 2019-2024 | Linx Reflux Management System |
| Lemaitre Vascular, INC. | $70.63 | 2022 | |
| Endo Pharmaceuticals INC. | $49.83 | 2021-2022 | |
| Smith+Nephew, INC. | $28.78 | 2023 | Stravix |
| Dilon Technologies, INC. | $23.18 | 2023 | Hemoblast Bellows |
| Aroa Biosurgery Incorporated | $22.15 | 2024 | |
| Tela Bio, INC. | $20.87 | 2022 | |
| Teleflex LLC | $14.08 | 2023 | Titan Sgs Standard Gastric Stapler |
| Endogastric Solutions, INC | $7.89 | 2023 | Esophyx |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jennifer Mcallaster listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.